Ades L - Search Results

1

Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation.

Boy M, Bisio V, Zhao LP, Guidez F, Schell B, Lereclus E, Henry G, Villemonteix J, Rodrigues-Lima F, Gagne K, Retiere C, Larcher L, Kim R, Clappier E, Sebert M, Mekinian A, Fain O, Caignard A, Espeli M, Balabanian K, Toubert A, Fenaux P, Ades L, Dulphy N. Boy M, et al. Among authors: ades l. Nat Commun. 2023 Feb 3;14(1):588. doi: 10.1038/s41467-023-36193-w. Nat Commun. 2023. PMID: 36737440 Free PMC article.

2

Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.

Ducastelle S, Adès L, Gardin C, Dombret H, Prébet T, Deconinck E, Rio B, Thomas X, Debotton S, Guerci A, Gratecos N, Stamatoullas A, Fegueux N, Dreyfus F, Fenaux P, Wattel E. Ducastelle S, et al. Among authors: ades l. Haematologica. 2006 Mar;91(3):373-6. Haematologica. 2006. PMID: 16531261

3

Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia.

Carvalho G, Fabre C, Braun T, Grosjean J, Ades L, Agou F, Tasdemir E, Boehrer S, Israel A, Véron M, Fenaux P, Kroemer G. Carvalho G, et al. Among authors: ades l. Oncogene. 2007 Apr 5;26(16):2299-307. doi: 10.1038/sj.onc.1210043. Epub 2006 Oct 16. Oncogene. 2007. PMID: 17043643

4

Is cytarabine required in the treatment of acute promyelocytic leukemia? Updated experience and review of the literature.

Adès L, Fenaux P. Adès L, et al. Clin Adv Hematol Oncol. 2006 Sep;4(9):678-82. Clin Adv Hematol Oncol. 2006. PMID: 17099625 Review. No abstract available.

5

NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia.

Fabre C, Carvalho G, Tasdemir E, Braun T, Adès L, Grosjean J, Boehrer S, Métivier D, Souquère S, Pierron G, Fenaux P, Kroemer G. Fabre C, et al. Among authors: ades l. Oncogene. 2007 Jun 14;26(28):4071-83. doi: 10.1038/sj.onc.1210187. Epub 2007 Jan 8. Oncogene. 2007. PMID: 17213804

6

Differentiating megakaryocytes in myelodysplastic syndromes succumb to mitochondrial derangement without caspase activation.

Braun T, Carvalho G, Grosjean J, Ades L, Fabre C, Boehrer S, Debili N, Fenaux P, Kroemer G. Braun T, et al. Among authors: ades l. Apoptosis. 2007 Jun;12(6):1101-8. doi: 10.1007/s10495-006-0030-z. Apoptosis. 2007. PMID: 17245643

7

Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study.

Boehrer S, Adès L, Braun T, Galluzzi L, Grosjean J, Fabre C, Le Roux G, Gardin C, Martin A, de Botton S, Fenaux P, Kroemer G. Boehrer S, et al. Among authors: ades l. Blood. 2008 Feb 15;111(4):2170-80. doi: 10.1182/blood-2007-07-100362. Epub 2007 Oct 9. Blood. 2008. PMID: 17925489 Free article.

8

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience.

Park S, Grabar S, Kelaidi C, Beyne-Rauzy O, Picard F, Bardet V, Coiteux V, Leroux G, Lepelley P, Daniel MT, Cheze S, Mahé B, Ferrant A, Ravoet C, Escoffre-Barbe M, Adès L, Vey N, Aljassem L, Stamatoullas A, Mannone L, Dombret H, Bourgeois K, Greenberg P, Fenaux P, Dreyfus F; GFM group (Groupe Francophone des Myélodysplasies). Park S, et al. Among authors: ades l. Blood. 2008 Jan 15;111(2):574-82. doi: 10.1182/blood-2007-06-096370. Epub 2007 Oct 16. Blood. 2008. PMID: 17940203 Free article. Clinical Trial.

9

Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison.

Boehrer S, Adès L, Galluzzi L, Tajeddine N, Tailler M, Gardin C, de Botton S, Fenaux P, Kroemer G. Boehrer S, et al. Among authors: ades l. Biochem Pharmacol. 2008 Dec 1;76(11):1417-25. doi: 10.1016/j.bcp.2008.05.024. Epub 2008 Jul 9. Biochem Pharmacol. 2008. PMID: 18617157

10

Flt3 receptor inhibition reduces constitutive NFkappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.

Grosjean-Raillard J, Adès L, Boehrer S, Tailler M, Fabre C, Braun T, De Botton S, Israel A, Fenaux P, Kroemer G. Grosjean-Raillard J, et al. Among authors: ades l. Apoptosis. 2008 Sep;13(9):1148-61. doi: 10.1007/s10495-008-0243-4. Apoptosis. 2008. PMID: 18670883

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

378 results

Search Page